Your browser doesn't support javascript.
loading
Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.
Wen, Sailan; Liu, Yuwu; Yang, Manyi; Yang, Keda; Huang, Jianghai; Feng, Deyun.
Affiliation
  • Wen S; Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
  • Liu Y; Department of Morphology, The Institute of Advanced Occupation Technology, Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China.
  • Yang M; National Hepatobiliary and Enteric Surgery Research Center, Department of Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
  • Yang K; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
  • Huang J; Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
  • Feng D; Department of Pathology, School of Basic Medical Sciences, Central South University, Changsha, Hunan 410013, P.R. China.
Oncol Rep ; 36(4): 2193-9, 2016 Oct.
Article in En | MEDLINE | ID: mdl-27509921

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Neuropeptide Y / Carcinoma, Hepatocellular / Proto-Oncogene Proteins c-akt / NIMA-Related Kinases / Liver Neoplasms Limits: Humans Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Neuropeptide Y / Carcinoma, Hepatocellular / Proto-Oncogene Proteins c-akt / NIMA-Related Kinases / Liver Neoplasms Limits: Humans Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2016 Document type: Article